Advances in the treatment of rheumatic diseases.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015232:Dinoprostone; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control; D006801:Humans; D011458:Prostaglandins E / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012459:Salicylates / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D011458:Prostaglandins E; D012459:Salicylates; D015232:Dinoprostone